[1]
P. Bonanni, D. Panatto, B. Dirodi, S. Boccalini, and R. Gasparini, “HPV vaccination and allocative efficiency: regional analysis of the costs and benefits with the bivalent AS04-adjuvanted vaccine, from the perspective of public health, for the prevention of cervical cancer and its pre-cancerous lesions”, FE, vol. 13, no. 2S, pp. 3–15, Nov. 2012.